Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy.

The Kaohsiung journal of medical sciences - 1 Aug 2020

Liang Wen-Chen, Wang Chen-Hua, Chen Wan-Zi, Kuo Yun-Ting, Lin Hsiu-Fen, Suzuki Shigeaki, Nishino Ichizo, Jong Yuh-Jyh

Abstract excerpt

Immune-mediated necrotizing myopathy (IMNM) has emerged as a new subgroup of idiopathic inflammatory myopathy in the past decade, associated with the presence of two autoantibodies against signal recognition particle and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR). We aim to analyze the clinical, pathological, and imaging phenotypes of the patients with anti-HMGCR myopathy in our cohort. Five patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Hydroxymethylglutaryl CoA Reductases

Share to Magnetic Resonance Imaging

Share to Muscles

Share to Muscular Diseases

Share to Taiwan

Source

Identifiers

PMID: 32666706
DOI: 10.1002/kjm2.12240

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy.PMID 32666706Read ↗

Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathySemantic proximity Read ↗

The pathogenesis of anti-signal recognition particle necrotizing myopathy: A ReviewSemantic proximity Read ↗

Anti-HMGCR MyopathySemantic proximity Read ↗

Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical-serological-pathological classification.Semantic proximity Read ↗

Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.Semantic proximity Read ↗

Clinical phenotypes and long-term outcomes of anti-SRP versus anti-HMGCR immune-mediated necrotising myopathy: a 13-year single-centre study.Semantic proximity Read ↗

Clinical Characteristics of Immune-Mediated Necrotizing Myopathy with Autoantibodies Recognizing the Signal Recognition Particle: A Retrospective Study of a Chinese CohortSemantic proximity Read ↗

Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy.Semantic proximity Read ↗

Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.Semantic proximity Read ↗

Immune-mediated statin myopathy.Semantic proximity Read ↗

Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.Semantic proximity Read ↗

Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.